Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin–bound paclitaxel in patients with advanced solid tumors

Author: Abu-Khalaf Maysa M.   Baumgart Megan A.   Gettinger Scott N.   Doddamane Indukala   Tuck David P.   Hou Shihe   Chen Nianhang   Sullivan Catherine   Lezon-Geyda Kimberly   Zelterman Daniel   Hatzis Christos   Deshpande Hari   Digiovanna Michael P.   Azodi Masoud   Schwartz Peter E.   Harris Lyndsay N.  

Publisher: Blackwell Publishing

E-ISSN: 1097-0142|121|11|1817-1826

ISSN: 0008-543X

Source: Cancer, Vol.121, Iss.11, 2015-06, pp. : 1817-1826

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content